Purpose of Review Traumatic stress has profound impacts on many domains of life, yet the mechanisms that confer risk for or resilience to the development of traumatic stress-related psychopathologies are still very much under investigation. The current review highlights recent developments in the field of traumatic stress epigenetics in humans. Recent Findings Recent results reveal traumatic stress-related epigenetic dysregulation in neural, endocrine, and immune system genes and associated networks. Emerging work combining imaging with epigenetic measures holds promise for addressing the correspondence between peripheral and central effects of traumatic stress. A growing literature is also documenting the transgenerational effects of prenatal stress exposures in humans. Summary Moving forward, increasing focus on epigenetic marks of traumatic stress in CNS tissue will create a clearer picture of the relevance of peripheral measures; PTSD brain banks will help in this regard. Similarly, leveraging multigenerational birth cohort data will do much to clarify the extent of transgenerational epigenetic effects of traumatic stress. Greater efforts should be made towards developing prospective studies with longitudinal design.
Introduction
An estimated 89.7% of adults have been exposed to at least one traumatic event in their lifetime [1] , with the norm being multiple trauma exposures. These events include instances in which threat to life is salient [2] . It is well known that traumatic stress exposure has profound sociological, psychological, and biological effects [3] . These effects can occur within any stage of life, but trauma exposure during physiological, and especially neural development, are particularly detrimental [4] .
Exposure to trauma can cause dysfunction within the hypothalamic-pituitary adrenal axis (HPA-axis) (Fig. 1) . and other biological systems, and is associated with the development of major depressive disorder (MDD) [8] , post-traumatic stress disorder (PTSD) [8] , and other mood and anxiety disorders. With PTSD in particular, individuals are required to have an exposure to trauma in order to be eligible for a diagnosis [2] , yet not all individuals who are exposed go on to develop the disorder; thus PTSD, as well as the broader assessment of traumatic stress, are especially useful for understanding the molecular mechanisms that confer risk for, or resilience to, this disorder. In particular, the molecular mechanisms that mediate interactions between genes and the environment are particularly salient and require further characterization.
To understand this vital topic, researchers have focused on an area of molecular biology known as epigenetics. There are three well-studied epigenetic mechanisms by which traumatic stressors can biologically embed themselves and therefore "get under the skin", and evidence exists for trauma-induced alterations for each of these mechanisms. First, DNA methylation (5mC) is the biochemical process by which a methyl group is added to the 5′-end of a cytosine residue, most often occurring when the cytosine residue is adjacent to a guanine residue (CpG) on a strand of DNA. Canonically, these additional chemical groups can act to sterically exclude the binding of the transcriptional machinery to the DNA, thereby altering the transcription of the respective genic region [9] . Second are post-translation histone tail modifications. Through the acetylation, methylation, phosphorylation, or other chemical modifications to the amino acid tails of histones, which are the protein octamers around which DNA is tightly wrapped during phases of transcriptional silence, the availability of regions of DNA for transcription is altered [10] . The final epigenetic mechanism of discussion by which traumatic stress can embed biologically is through small non-coding RNA (sncRNA) and long non-coding RNA (lncRNA) molecules. In brief, these molecules generally function by binding to mRNA that has already been transcribed, either enhancing or limiting their ability to interact with proteins or to be translated into proteins themselves. These snc/lncRNA molecules can also form RNA:protein complexes which then bind to unwound DNA. This binding can facilitate the recruitment of proteins responsible for applying more epigenetic marks to both the DNA itself and the amino acid histone tails nearby [11] .
Although this list of epigenetic mechanisms is not comprehensive, it does represent the most frequently studied and salient mechanisms with respect to traumatic stress. Taken together, these mechanisms alter the expression of genes [12] , functionally alter downstream biological processes [13] , and associate with numerous traumatic stress-related psychopathologies [14] . Based on the involvement of the brain, the HPA-axis, and the immune system in the response to traumatic stress, the current review highlights recent research in the field of traumatic stress epigenetics, and offers a neuro-immuno-endocrine framework of organization by which the research will be presented, as well as an overview of transgenerational transmission mechanisms.
Importantly, the field has increasingly recognized that genome-wide association studies (GWAS) require large cohort sample sizes to combat multiple hypothesis testing error rates (type I error rates), and also to more completely grasp variability within measurements. This concept holds true for Fig. 1 a HPA-axis long-range feedback mechanism. In response to perceived stress, brain regions associated with emotional reactivity and memory, including the prefrontal cortex, amygdala, and hippocampus are activated. Through afferent axonal connections, these regions activate (green arrow) the HPA-axis' neural hub, the paraventricular nucleus (PVN) of the hypothalamus, to release both vasopressin and, importantly, corticotropin-releasing hormone (CRH) [5] . From there, CRH acts in a stimulatory manner on the anterior pituitary gland to release adrenal corticotropic hormone (ACTH). ACTH is released into the bloodstream, whereupon it travels to the adrenal cortices of the kidneys, stimulating the release of glucocorticoids (GCs), such as cortisol. These stress hormones act ubiquitously (black arrow) throughout many tissues in the body and contribute to critical immunological, metabolic, cardiac, and homeostatic functions [6] . Importantly, GCs also act mechanistically in and around the CNS, including serving as a long-range negative feedback mechanism to inhibit further HPA-axis activity (red arrow). b HPA-axis ultra-shortrange feedback mechanism. GCs also bind directly to the NR3C1 protein, glucocorticoid receptor (GR). GR commonly forms a complex with other proteins including p23, HSP90, and FKBP5. When the FKBP5 protein is present in the complex, GC binding affinity is reduced. However, when GC binding does occur, FKBP5 is removed from the complex in exchange for FKBP4 and Dynein. These proteins facilitate the chaperone of the GC:GR complex across the nuclear membrane of the cell. Once inside the nucleus of the cell, the complex interacts with glucocorticoid response elements (GREs) which function to regulate the expression of numerous genes, having wide-reaching biological effects. When the complex binds GREs in the FKBP5 gene, the transcription and translation of FKBP5 is increased. This increase in FKBP5 results in reduced GC sensitivity, and the ultra-short-range feedback loop is complete. Figure adapted from Psychoneuroendocrinology, volume 34, E.B. Binder, The role of FKBP5: a co-chaperone of the glucocorticoid receptor in the pathogenesis and therapy of affective and anxiety disorders, S186-S195, 2009 [7] , with permission from Elsevier [20]
H P A -a x i s Interleukin 1, hematopoietin-1
IL1
Includes both IL1A and IL1B. These protein products are cytokines which signal to other factors involved in immune response, inflammation response, and hematopoiesis.
[26]
Immune system
Interleukin 6, B cell stimulatory factor 2
IL6
The protein product of the IL6 gene functions as a cytokine, communicating with B cells to signal their maturation, and facilitating the inflammatory response.
Interleukin 10, cytokine synthesis inhibitory factor
IL10
This gene encodes a cytokine which functions to downregulate T helper cell cytokines, MHC class 2 agonists, and costimulatory macrophage factors.
Tumor necrosis factor TNF The protein product of the TNF gene is secreted by macrophages, and function in numerous ways as a proinflammatory cytokine.
Immune system C-X-C motif chemokine ligand 8, interleukin 8
CXCL8
The CXCL8 protein product is a chemokine, mediating the response to inflammation, and attracting neutrophils, basophils, and T cells.
[ 35] Immune system Interleukin 6, lymphocyte chemoattractant factor
IL16
The IL16 gene protein product facilitates migration of lymphocytes, and modulates T cell activation.
[35]
Interleukin 18, interferon-gamma-inducing factor
IL18
The protein product of this gene stimulates helper T cell and NK cell activity, acting as a proinflammatory cytokine.
Insulin-like growth factor 2
IGF2
An imprinted gene, involved in development and growth, expressed only by the paternal allele.
[ 35, 75] Development and growth H19, imprinted maternally expressed transcript (non-protein coding)
H19
An imprinted gene, producing a tumor-suppressing long non-coding RNA, expressed only by the maternal allele, located near IGF2.
Epigenetic regulation
Interferon gamma
IFNG
The protein product of this gene is a soluble cytokine which acts to trigger cellular responses to viral/microbial infections, stimulating NK cells. [36, 37] Immune system
Interleukin 12B
IL12B
The IL12B protein product is a cytokine that interacts with T cells and NK cells, and is suggested to play a role in multiple sclerosis.
[ 36, 37] Immune system
Interleukin 2, T cell growth factor
IL2
The IL2 protein is a cytokine which signals T and B cell proliferation.
[39]
Catechol-O-methyltransferase
COMT
The COMT gene encodes an enzyme responsible for the catabolism of catecholamines such as dopamine (DA) and norephinephrine (NE).
[43]
C N S Brain-derived neurotrophic factor BDNF The BDNF protein product encodes a nerve growth factor, promoting neuronal survival in the brain and in the periphery.
[ 44, 68, 75] C N S 
Implicated Biological Systems

HPA-Axis
The HPA-axis plays a pivotal role in the body's response to both typical and elevated levels of stress. For this reason, genes belonging to the HPA-axis pathway have been the focus of recent and early investigations in the field of traumatic stress epigenetics (Table 1) , attempting to associate epigenetic marks in either the periphery or central nervous system (CNS) with traumatic event exposure, PTSD status, or PTSD symptom severity. Additionally, attempts to understand risk vs. resilience in the context of HPA-axis genes have been made. Two proteins playing pivotal roles within the HPA-axis are translated from the FKBP5 and NR3C1 transcripts. In a seminal study investigating epigenetic mechanisms mediating the relationship between childhood trauma exposure (CTE), and FKBP5 genotype, Klengel et al. 2013 [16• ] measured 5mC of the FKBP5 promoter region, intron 2, 5, and 7, as derived from peripheral blood cells. Researchers found significant associations between 5mC at discrete CpG sites, CTE, and FKBP5 genotype. The three CpG sites of interest fell within intron 7, and were located adjacent to a genomic region sensitive to glucocorticoid (GC) regulation, suggesting a functionally relevant, long-lasting epigenetic effect of CTE, potentially originating in HPA-axis dysfunction. Additionally, expression of 76 transcripts was correlated with plasma cortisol levels, with the strongest associations present in FKBP5 protective allele carriers. To lend functional weight to their human results, researchers used in vitro hippocampal cell culture to show that exposure to dexamethasone (DEX), a synthetic GC, decreased 5mC at the same sites as observed in blood. Importantly, differential 5mC findings in peripheral blood were also represented in their CNS tissue model, establishing that alterations in the periphery can be indicative of epigenetic CNS dysregulation. These results set the tone for the field in the coming years to study HPA-axis dysregulation in relation to traumatic stress and epigenetic variation in both the periphery and CNS.
Additional and notable work investigating traumatic stressrelated epigenetic variation in HPA-axis genes includes a psychotherapy-focused investigation by Yehuda and colleagues (2013) [17] . In this study, investigators measured Studies discussed
Primary biological system 5-hydroxytryptamine receptor 3A
HTR3A
The HTR3A protein product is subunit 3 of a ligand-gated ion channel, residing on the post-synaptic terminal of serotonergic synapses, playing a role in synaptic transmission.
[ 45, 69] C N S Dedicator of cytokinesis 2
DOCK2
The DOCK2 protein product plays a role in facilitating lymphocyte migration, as it functions to remodel actin cytoskeletons.
[51]
Spindle and kinetochore-associated complex subunit 2 SKA2 SKA2 protein interacts with the GR, NR3C1, playing a pivotal role in the HPA-axis and stress reactivity pathways. [60] [61] [62] [63] H P A -a x i s Double-stranded RNA-specific endoribonuclease
DICER1
Encodes an enzyme responsible for the development of mature microRNAs.
[71]
MicroRNA 3130-5p (MicroRNA 3130-1)
miR-3130-5p (miR-3130-1) A mature miRNA sequence, which partly makes up the miR-3130-1 stem loop sequence, which targets numerous mRNAs, including MRPL35 mRNA. Its dysregulation has been implicated in cancer as well as mental health disorders.
Mitochondrial ribosomal protein L35
MRPL35
The protein product of this gene encodes the large 39S subunit protein of the mammalian mitochondrial ribosome.
Protein translation Solute carrier family 6 member 4
SLC6A4
The SLC6A4 protein functions as a reuptake transporter of serotonin from the synaptic cleft into presynaptic neurons. [66, 67] C N S FKBP5 and NR3C1 promoter 5mC in lymphocytes as predictors of psychotherapy outcome in combat veterans with PTSD. Results showed that increased NR3C1 exon 1F promoter 5mC measured pre-treatment did predict positive treatment outcome, although 5mC itself was not altered between pre-and post-treatment. On the other hand, FKBP5 exon 1 promoter pre-treatment 5mC did not predict treatment outcome, but did decrease among those who responded to therapy. Among treatment-responders, FKBP5 mRNA expression was elevated, compared to non-responders. Although implications from these results are limited by small sample size, results build upon earlier cross-sectional work suggesting that HPA-axis genes are subject to epigenetic alteration, and provide insight into how psychotherapy alters epigenetic and transcriptional states. Labonte et al. 2014 [18] showed similar results. Their study measured NR3C1 5mC as collected in peripheral T lymphocytes, and showed that subjects with lifetime PTSD diagnoses had lower morning cortisol release, increased mRNA expression of NR3C1 total transcripts, 1B and 1C transcripts, and also had decreased 5mC of the 1B and 1C promoter regions. Results reinforce the notion that trauma exposure-related psychopathology is associated with epigenetic alteration of the NR3C1 gene, with functional transcription and neuroendocrine alterations occurring as well.
With a larger sample size compared to earlier work [17] , Yehuda and colleagues (2015) [19] found decreased NR3C1 exon 1F promoter 5mC, as measured in peripheral blood mononuclear cells (PBMCs), in combat veterans with PTSD compared to combat veterans without PTSD. 5mC at this locus was also associated with three measures of functional GC activity. Results highlight that decreased NR3C1 5mC could either confer risk of PTSD development or be a result of PTSD development, and that epigenetic alteration of NR3C1 could functionally alter neuroendocrine system outputs.
Although 5mC change appears to be a salient factor related to the traumatic stress response, other epigenetic alterations have also been documented. For example, childhood maltreatment (CM) was associated with differential 5mC in a site proximal to miR124-3, which is a regulator of NR3C1 mRNA transcription [20] . Results indicate that different types of traumatic stress are capable of epigenetic reprogramming of genes that themselves encode epigenetic regulatory factors.
Although the previous studies demonstrate the importance of NR3C1 and other HPA-axis genes in traumatic stress, one important shortcoming is their overwhelmingly cross-sectional nature, which hampers causal inference. Recent efforts have been made to circumvent these shortcomings by utilizing longitudinal sampling. One such study sampled whole blood of veterans before and after combat exposure. From both time points, they measured NR3C1 5mC in the 1F exon, as well as NR3C1 mRNA. Importantly, they found that both trauma exposure during combat and development of mental health problems 6 months after deployment were associated with an increase in 5mC, including sites showing correlation between 5mC and expression, over that time period. Importantly, they found that pre-deployment NR3C1 exon 1F 5mC did not predict post-deployment psychopathologies [21•] . This is the first study to present prospective evidence of increases in NR3C1 5mC in response to trauma exposure, and results point towards the importance of considering functional 5mC in conjunction with mRNA expression of the associated gene.
Immune System
The HPA-axis plays a key role in modulating the immune system, and inflammatory processes specifically [22, 23] . GCs released by the adrenal cortices play an antiinflammatory role [24] , and dictate immune cell trafficking, maturation, and differentiation [25] , while controlling expression of signaling cytokines such as IL-1, IL-6, IL-10, and TNF-alpha [26] . These cytokines, in turn, allow the immune system to regulate the CNS [27] . Traumatic stressors have profound effects on the immune and specifically the inflammatory responses throughout the lifetime; these altered inflammatory states confer risk of psychopathologies [28] [29] [30] . Molecular mechanisms by which these alterations are conferred are not well understood; recent research in the field of traumatic stress epigenetics has investigated this question.
Mehta et al. 2013 [31] utilized genome-scale approaches to investigate 5mC and mRNA expression in peripheral blood cells of trauma-exposed subjects who had lifetime history of PTSD versus trauma-exposed no PTSD subjects. Of those with lifetime PTSD, they also investigated differences between subjects who had experienced CM versus those who had not. Differential enrichment at the mRNA transcript and network levels among the three groups revealed largely nonoverlapping results, with gene expression changes that were mediated most strongly by 5mC changes in the CM group; however, overlapping results showed enrichment of cell survival, development, migration, and adhesion networks, T cell activation, and immune networks. Results indicate distinct peripheral epigenetic effects of traumatic stress brought on by CM, in particular within gene networks involved in immune regulation. Epigenetic dysregulation in immune system genes has been strongly implicated in earlier genome-scale studies of traumatic stress [32, 33] , including one study examining the emergence of PTSD-associated CpG sites during human evolution [34] .
Bolstering the implication of epigenetic dysregulation of immune system genes, Rusiecki et al. 2013 [35] investigated promoter region 5mC of, interleukin (IL)-8 (IL8), IL16, and IL18 genes in serum, as well as the insulin-like growth factor 2 (IGF2), long non-coding RNA transcript H19 (H19). Using a longitudinal design, they found differences between pre-and post-deployment 5mC at H19 and IL18 loci: non-PTSD controls showed decreased 5mC at both H19 and IL18, whereas PTSD subjects only showed increased IL18 5mC. Moreover, pre-deployment 5mC levels in IL8 were lower among those who later became cases post-deployment. Results show that both pre-existing epigenetic states and changes pre-to posttrauma can identify individuals who are susceptible vs. resilient to traumatic stress.
Departing from 5mC as the main epigenetic mechanism of interest, Zhou et al. 2014 [36] showed that in PTSD patients, miRNA expression was significantly dysregulated in transcripts targeting immune system signaling pathways, as measured in PBMCs. Importantly, these changes were associated with differential plasma levels of IFN-γ and IL-17, showing the functional effects of miRNA dysregulation associated with PTSD. More recent research from the same team has shown complex interactions among epigenetic mechanisms regulating immune system functions. Bam et al. 2016 [37] investigated genome-wide histone H3 tri-methylation, 5mC, and miRNA expression from PBMCs in veterans with PTSD vs. non-traumaexposed controls. Results showed differential histone H3 tri-methylation at four sites, differential 5mC at promoters of IL-12B and interferon gamma (IFNG), and elevated IL-12 mRNA transcript levels. They also showed that miRNA regulation of IFNG and IL-12 was significantly decreased in PTSD patients. In a novel follow-up study from the same lab, Bam et al. 2016 [38] combined genome-wide RNAseq and miRNA data in PBMCs, albeit with a small sample size. They showed significant negative correlations between mRNAs and miRNAs playing salient roles specific to immune system functions including cytokine-based inflammation, CCKR, and interleukin signaling, among others.
Further implicating immune system dysregulation in traumatized populations, Powers et al. 2016 [39] conducted a large GWAS of emotional regulation in a highly traumatized, minority, urban sample. In males, they found a SNP located in the IL-2A gene (rs6602398) that was associated with emotional dysregulation, PTSD, MDD, and differential 5mC as measured in whole blood. Their results point towards sex differences and the role of genotype in trauma exposure-related psychopathologies, as well as more complex endophenotypes relevant to PTSD, such as emotion regulation.
Overall, epigenetic regulation of the immune system in response to trauma exposure appears to play a key role in indexing risk vs. resilience in relation to the development of PTSD. Numerous epigenetic mechanisms have been implicated in peripheral tissues including miRNA, histone modifications, and 5mC; numerous genes, transcripts, and proteins have also been implicated. Results suggest a complex interaction of the HPA-axis, and immune systems with many molecular factors mediating these relationships.
Central Nervous System
The CNS plays a key role in the mediation of both HPA and immune reactions to stress [40] , and epigenetic regulation of this mediation occurs at the CNS level as well [41] . Although it is challenging to make inferences regarding the contribution of epigenetic variation in CNS-related genes to CNS function when measured in blood, such measures can be used as potential biomarkers of risk and resilience to traumatic stress, as interactions among the CNS, HPA-axis and immune system may produce epigenetic alterations in factors circulating in peripheral tissues [42] .
In the earliest study of its kind, Norrholm and colleagues (2013) [43] investigated the epigenetic and genetic regulation of the COMT gene in relation to an endophenotype of PTSD, the fear-potentiated startle response. As measured in whole blood, they found that subjects with the PTSD riskassociated MET/MET genotype (rs4680) showed increased fear-potentiated startle response compared to VAL/MET or VAL/VAL carriers. Importantly, MET/MET genotype was also associated with 5mC of four CpG sites in the COMT promoter region, two of which were associated with the increased fear-potentiated startle response. This study highlights how an endophenotype of PTSD associates with epigenetic variation as measured in the blood, with a mediating effect of genotype.
In a more recent study, Kim et al. 2017 [44] investigated the effect of distant trauma exposure and PTSD status in Vietnam War veterans. They measured BDNF promoter 5mC from whole blood, finding that subjects with PTSD had increased promoter 5mC compared to those with trauma exposure but without PTSD. Results indicated that peripheral BDNF promoter 5mC could confer risk of development of PTSD. Perroud et al. 2016 [45] investigated the role of CM in relation to 5mC of the serotonin 3A receptor gene (5HTR3A) as well as genotype, outside of the context of PTSD. By measuring promoter 5mC in whole blood and assaying genotype of the SNP rs1062612, they found that CM was associated with: symptom severity of ADHD, borderline personality, and bipolar disorder, as well as differential 5mC of two promoter region sites, with genotype significantly mediating the relationships. Results show that peripheral 5HTR3A promoter 5mC is a biomarker of psychopathological symptom severity, and, similar to the COMT results reported by Norrholm and colleagues (2013) , that genotype plays a salient role in mediating the relationship.
Investigating a cohort in which all subjects experienced the same traumatic event, Kuan et al. 2017 [46] conducted a large-scale epigenome-wide association study (EWAS) on World Trade Center disaster first responders, investigating genome-wide 5mC and both PTSD and MDD in whole blood. All subjects were trauma-exposed; analyses were carried out comparing lifetime PTSD vs. never and lifetime MDD vs. never. No single CpG site was significantly differentially methylated; however, pathway analyses of nominally differentially methylated sites associated with PTSD implicated synaptic plasticity, oxytocin signaling, cholinergic synapse, and inflammatory disease pathways as being dysregulated in this disorder.
Although recent research in the field of traumatic stress epigenetics has focused on the inter-related HPA-axis, CNS, and immune systems, evidence exists for epigenetic dysregulation of genes and pathways outside of the aforementioned systems. Common findings point to association of traumatic stress exposure with dysregulation of 5mC aging mechanisms [47] , and epigenetic alterations to genes encoding epigenetic machinery itself [48] [49] [50] . A recent EWAS study also implicates a gene thought to play a role in Alzheimer's pathology (DOCK2) [51] . Results from these recent epigenetics studies focus on genes mediating synaptic transmission, as measured in the periphery, although inherent limitations to this approach exist.
Imaging Epigenetics
A common shortfall of current epigenetic work related to traumatic stress in humans is the inability to measure epigenetic markers in the living human brain. The majority of studies reviewed here report epigenetic measurements derived from peripheral tissues such as saliva or blood. Studies based on peripheral tissue inherently limit the conclusions that can be drawn in relation to CNS function, as it remains unknown to what extent epigenetic markers taken outside the CNS functionally represent concurrent biological processes or dysregulation occurring in the brain. More comprehensive coverage of limitations is discussed elsewhere [52] . To this end, the most common methods to circumvent this peripheral problem include testing animal models of stress/trauma and mental health disorders, and by assaying epigenetic markers in human postmortem brain tissue. These methodologies have both strengths and limitations, including confounding of biological measurements by postmortem interval as a major limitation, as has been previously reviewed [53, 54] . Interestingly, the current review could not identify recent published work performed using postmortem, brain-based epigenetic measurements from individuals with lifetime trauma exposure. Another recently employed method that helps circumvent the peripheral problem is the use of neuroimaging techniques to capture neural endophenotypes, especially neuroanatomical morphology (structural MRI) and/or functional reactions to stress or emotional paradigms (functional MRI). In pairing this information with epigenetic data, researchers can index functional biological endophenotypes in the brain with easily accessible peripheral tissue measures of epigenetic marks. Recent work in traumatic stress epigenetics has adopted this approach.
Traumatic stress has a well-documented impact on the HPA-axis, and also has a salient impact on memory and emotional regulation, as the amygdala (AMYG), prefrontal-cortex (PFC), and hippocampus (HIPP) are neurally integrated within the fronto-limbic pathway (Table 2 ) [57] . On this note, Vukojevic et al. 2014 [58] found that in Rwandan genocide survivors, increased NR3C1 NGFI-A (nerve growth factorinduced protein A) binding site 5mC, as measured in saliva, was associated with less intrusive traumatic thoughts, and a reduced risk of PTSD symptoms in males. Using fMRI, researchers found that increased NR3C1 5mC was associated with reduction in a memory task performance in men, but not women. Results warrant increased consideration of sex differences, and that epigenetic alterations of NR3C1 can impact particular symptom domains of strong relevance to PTSD. Other labs have also associated differential NR3C1 5mC with trauma-related fMRI endophenotypes in the mPFC [59] .
In a recent study of trauma-exposed veterans, Sadeh and colleagues (2016) [60] investigated 5mC of SKA2 in whole blood. Differential 5mC methylation of SKA2 predicts suicidal behavior and PTSD status [61] , the development of PTSD after military deployment [62] , as well as aberrant internalizing psychopathology [63] . In the current study, investigators found that an increase of SKA2 5mC at cg13989295, located [55] . [60, 64] C N S Anterior cingulate cortex ACC Emotional regulation, error detection, inhibitory control, empathy, decision making [56] .
[68] C N S in the fourth exon, was associated with decreased PFC thickness bilaterally at the frontal pole and superior frontal gyrus, and in the right hemisphere at the orbitofrontal cortex (OBFC) and inferior frontal gyrus. Additionally, PTSD symptom severity was positively correlated with SKA2 5mC and negatively correlated with PFC thickness [60] . Results from this study, and others, show that SKA2 methylation can be considered a peripheral biomarker of both PTSD symptom severity and a PFC thinning endophenotype in trauma-exposed war veterans. Further research on peripheral measures of HPA-axis genes show that FKBP5 mRNA in PTSD subjects is significantly lowered, and that this is associated with reduced HIPP, medial OBFC, but not AMYG volumes as measures by structural MRI [64] . Based on this recent research, a relationship between epigenetic dysregulation of HPA-axis genes and dysregulation of fronto-limbic neural pathways is evident. Although much work has been done to investigate the role of HPA-axis genes within the field of imaging epigenetics, a focus on CNS-relevant genes is also represented in this literature. Building on earlier seminal work that used positron emission tomography (PET) imaging approaches to directly assess in vivo serotonin levels in the CNS [65] , Booji and colleagues (2015) [66] showed SLC6A4 promoter 5mC of the sites mentioned above were significantly associated with CTE, as well as reduced HIPP volume (using structural MRI), once again providing evidence that the biological embedding of traumatic stress can have significant neural impacts, and then these neural endophenotypes can be indexed by peripheral measures of 5mC. In a similar vein, Frodl et al. 2015 [67] found that CM was associated with increased promoter SLC6A4 5mC levels as measured in blood, also showing increased activation in the left anterior insular cortex, and left frontal inferior operculum in response to negative emotional stimuli. Other labs have also associated differential BDNF and HTR3A 5mC with trauma-related fMRI endophenotypes in the ACC and vmPFC [68] and mPFC [69] . Overall, recent research implicates a relationship between trauma exposure and epigenetic dysregulation of the CNS serotonergic system, as well as brain regions important for emotional regulation.
Although most recent imaging epigenetics studies focus on HPA-axis and CNS candidate genes, recent work from the Grady Trauma Project [70] investigated the role of DICER1. Researchers found that decreased DICER1 expression, measured in blood, was associated with increased AMYG activity, as measured by fMRI in a fearful stimuli paradigm. Results suggest trauma exposure is associated with AMYG overreactivity to stressful stimuli, and that this neural phenotype can be indexed as measured by DICER1 mRNA in the blood. Wingo and colleagues further showed that in trauma-exposed cases with PTSD/MDD, expression of miRNA miR-3130-5p was downregulated in comparison to trauma-exposed controls in discovery and replication cohorts, and this downregulation was associated with upregulation of one of its mRNA targets, MRPL35 [71] . Results from this study lend evidence of epigenetic regulation in relevant mRNA transcripts associating with neural activity implicated in PTSD, and also point to mechanisms mediating the development of psychopathology in groups that have been exposed to trauma.
The majority of studies presented above focus on candidate genes that have previously been implicated in traumatic stress reactivity. In a novel study carried out using Iraq/Afghanistan war veterans, two separate models of DNA methylation aging were compared [72, 73] . These models use 5mC measures from whole blood to index chronological age. It was found that PTSD symptom severity throughout the lifetime was associated with Hannum method 5mC age estimates, and these age estimates were associated with reduced white matter fiber tract integrity in the genu of the corpus callosum, as measured by diffusion tensor MRI [74•] . Results point to the possibility that traumatic stress exposure from warzone combat has significant effects on neural integrity, and that this effect can be indexed in the periphery through Hannum 5mC age.
Overall, recent research has utilized fMRI, structural MRI, diffusion tensor imaging, and PET methods to identify relationships between trauma exposure, PTSD status, and epigenetic dysregulation of HPA-axis, CNS, epigenetic machinery, and CpGm age-related genes.
Transgenerational Epigenetic Effects of Traumatic Stress
Recent work has provided evidence that prenatal exposures may also shape differential risk for/resilience to traumatic stress and leave imprints of trauma exposure that persists postnatally. The majority of these transgenerational studies show a correlation between parental PTSD and its impact on their offspring. Although the symptoms of transgenerational transmission among children are various and different factors appear to play a role in the transgenerational transmission of PTSD, recent studies show evidence of biological and epigenetic effects [75-77, 78•, 79] .
As with many of the studies reviewed earlier, this transgenerational work has focused largely on genes belonging to the HPA-axis, due to their role in mediating the stress response both centrally and peripherally. In the earliest work, Mulligan and colleagues [75] investigated pregnant women and their resulting offspring residing in the Eastern Democratic Republic of Congo (DRC) to assess the impact of exposure to financial, psychosocial, and war stress on 5mC of NR3C1. Of these three stress-related domains, war stress showed the strongest, positive correlation with NR3C1 5mC when measured in cord blood, but showed no association with 5mC when measured in maternal venous blood. This work was followed by a broader investigation into additional HPA-axis genes assessed in both blood and placental tissues in the same mother-newborn dyads [76] . War-related trauma was moderately associated with 5mC in three of the four genes examined (CRH, NR3C1, FKBP5). As in the earlier work [75] , higher NR3C1 cord blood 5mC was associated with lower birth weight, a pattern that was also newly identified in this study for 5mC in CRH. Collectively, these results suggest that prenatal stress exposure has broad impact on epigenetic regulation of HPA-axis genes, in a manner that impacts offspring phenotype. Of note, the DRC-focused study has also examined genes outside the HPA-axis, including BDNF, IGF1, IGF2, and loci involved in maintaining or removing DNA methylation marks [76, 77] .
In contrast to the earliest NR3C1-focused work in Eastern DRC [75] , work investigating the transgenerational effects of exposure to the Rwandan genocide identified increased 5mC in NR3C1 in both exposed mothers and their offspring who were exposed in utero-although these effects were more pronounced in the exposed offspring than the exposed mothers [78•] . The divergent findings regarding 5mC of NR3C1 in exposed mothers in these two studies may be due to severity of traumatic exposures and/or analytic methods, both of which varied between studies; of note, in the subsequent study by Mulligan and colleagues [76] , war stress was associated with increased 5mC in this locus in maternal venous blood. Importantly, in the Rwandan study, the 5mC-based findings were accompanied by results showing reduced cortisol levels in genocide-exposed mothers and offspring, as well as reduced plasma glucocorticoid receptor and increased mineralocorticoid receptor levels [78•] , suggesting broad and sustained alterations in stress biology among those exposed to the Rwandan genocide that were detectable nearly 20 years after exposure.
Additional insight into the lasting impact of genocide exposure was provided by Yehuda and colleagues, who investigated 5mC of NR3C1 in Holocaust survivors in relation to PTSD. A complex pattern emerged in which parental PTSD was shown to associate with differential, blood-derived 5mC in Holocaust survivor offspring, but in a manner that differed depending on which parent was affected [80] . Similar to the Rwandan study, Yehuda and colleagues demonstrated functional effects of this differential 5mC by showing that lower NR3C1 5mC was associated with greater cortisol suppression following dexamethasone administration. Although the direction of 5mC effects differs with that identified in the Rwandan study, which did not specifically examine the impact of PTSD in association with NR3C1, this study provides further evidence of the lasting epigenetic impact of exposure to genocide, as many of the Holocaust survivor offspring were conceived after parental Holocaust exposure [80] . Subsequent work by the same research group showed that Holocaust exposure was associated with differential 5mC in FKBP5 in both exposed parents and offspring, when compared to 5mC levels observed in demographically matched parent and offspring control groups [79] . Importantly, these effects were observed when controlling for PTSD, suggesting that genocide exposure itself may leave lasting imprints on the epigenome of exposed individuals and their offspring, even when the exposure occurs pre-conception.
The studies described above have all focused on the epigenetic impact of traumatic stress exposure between one generation and the next, with the bulk of studies being performed on such exposures occurring during gestation. An outstanding question is to what extent such epigenetic effects might be observed across multiple generations. The first report to partially address this question in humans examined the association between grandmaternal exposure to intimate partner and community and domestic violence during pregnancy, and differential 5mC in grandchildren [81] . This EWAS investigation, which was conducted in DNA derived from saliva, identified CpG sites in 5 genes that showed differential 5mC in association with exposure to community and domestic violence. Although none of these genes fell into the pathways typically investigated in such studies, such as the HPA-axis, immune or inflammatory pathways, one of the genes, CFTR, was associated with PTSD and depression symptoms among children in the study, and had been previously identified as showing differential 5mC among institutionalized adolescents with a history of adversity in a separate study [82] . While findings from this work await replication, and do not address the question of concordant/discordant differential 5mC patterns in the maternal generation or within the grandmaternal generation, this study represents an important step towards assessing epigenetic effects of traumatic exposure that span multiple generations in humans. Further investigations would clarify the pathways through which this transgenerational transmission of PTSD affects younger generations on a large scale.
Conclusions
The role of epigenetic mechanisms in relation to traumatic stress exposure has been carefully investigated in recent years, and, as summarized in this brief review, much of this work has focused on dysregulation of genes involved in the HPA-axis, CNS, and immune systems. The vast majority of these have relied on peripheral tissues such as blood and saliva; thus, in many instances, it remains unknown whether epigenetic marks as measured in the periphery are indicative of what is occurring in etiological tissues such as the CNS. To address this, the field has recently focused on combining neuroimaging information with epigenetic data to index CNS activity with peripheral measures of epigenetic markers. Neural activity in brain regions responsible for emotional regulation/ processing and memory has been characterized in relation to traumatic stress exposure and related psychopathologies. More studies of this nature should be carried out, and measures of epigenetic marks in the CNS should also be a focus. The latter will be facilitated in the coming years with the development of PTSD brain banks, such as the National Posttraumatic Stress Disorder Brain Bank and the PTSD collection being developed at McLean Hospital in partnership with Cohen Veterans Bioscience. In addition, emerging work has begun to identify epigenetic associations with traumatic exposures that persist beyond one generation. The establishment and/or testing of data from birth cohorts that span multiple generations, such as the Avon Longitudinal Study of Parents and Children [83] and the Drakenstein Child Health Study [84] , will greatly enhance the ability to identify replicable epigenetic effects of traumatic exposures that persist across generations.
In all, the field has taken great steps in elucidating the role of epigenetic mechanisms regulating the HPA-axis, CNS, and immune responses to traumatic stress. With continued advances in molecular biology techniques, bioinformatics methods, and study design the picture is sure to become clearer.
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